These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 235488)

  • 1. T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.
    Bro-Jorgensen K; Güttler F; Jorgensen PN; Volkert M
    Infect Immun; 1975 Apr; 11(4):622-9. PubMed ID: 235488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in the immune system of mice infected with lymphocytic choriomeningitis virus.
    Bro-Jorgensen K; Volkert M
    Infect Immun; 1974 Apr; 9(4):605-14. PubMed ID: 4595753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets.
    Johnson ED; Cole GA
    J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of parental lymphoid cells on the production of 19S and 7S antibodies in F1 hybrid mice.
    Lindholm L; Strannegård O
    Int Arch Allergy Appl Immunol; 1974; 47(4):508-19. PubMed ID: 4153381
    [No Abstract]   [Full Text] [Related]  

  • 5. Restoration of in vitro immune responsiveness of mastocytoma-suppressed splenocytes by activated T cells.
    Kamo I; Patel C; Patel N; Friedman H
    J Immunol; 1975 Aug; 115(2):382-6. PubMed ID: 807635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.
    Doherty PC; Zinkernagel RM; Ramshaw IA
    J Immunol; 1974 Apr; 112(4):1548-52. PubMed ID: 4592605
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen.
    Braley-Mullen H; Sharp GC
    Cell Immunol; 1974 Apr; 12(1):49-60. PubMed ID: 4156496
    [No Abstract]   [Full Text] [Related]  

  • 8. Elimination of suppressor T-cells in mice undergoing a graft-versus-host reaction expressed by increased response to polyvinylpyrrolidone (PVP).
    Rotter V; Trainin N
    Cell Immunol; 1975 Jul; 18(1):199-209. PubMed ID: 237632
    [No Abstract]   [Full Text] [Related]  

  • 9. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative distribution of cytotoxic lymphocytes and of alloantibody-forming cells in albumin density gradients.
    Pelet J; Brunner KT; Nordin AA; Cerottini JC
    Eur J Immunol; 1971 Aug; 1(4):238-42. PubMed ID: 5003410
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the immunological capacity of germ-free mouse radiation chimeras. II. Thymus cell function in a humoral immune response to sheep erythrocytes.
    Loughman BE; Nordin AA
    Cell Immunol; 1973 Oct; 9(1):118-26. PubMed ID: 4582619
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of T- and B-lymphocytes in the immune response to the protein exotoxin and the lipopolysaccharide antigens of Vibrio cholerae.
    Kately JR; Patel CB; Friedman H
    Ann N Y Acad Sci; 1975 Feb; 249():404-12. PubMed ID: 1093472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymus cell population exerting a regulatory function in the immune response of mice to polyvinyl pyrrolidone.
    Rotter V; Trainin N
    Cell Immunol; 1974 Jul; 13(1):76-86. PubMed ID: 4615810
    [No Abstract]   [Full Text] [Related]  

  • 15. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.
    Zinkernagel RM; Doherty PC
    Nature; 1974 Apr; 248(5450):701-2. PubMed ID: 4133807
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the immunological capacity of germ-free mouse radiation chimeras. I. Chimerism and humoral immune response.
    Loughman BE; Nordin AA; Bealmear PM
    Cell Immunol; 1973 Oct; 9(1):104-17. PubMed ID: 4582618
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient impaired cell-mediated tumor immunity after acute infection with lymphocytic choriomeningitis virus.
    Güttler F; Bro-Jorgensen K; Jorgensen PN
    Scand J Immunol; 1975; 4(4):327-36. PubMed ID: 1188321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytes and leukemia virus infection: effects on bone marrow and thymus cell responses and interactions.
    Ceglowski WS; LaBadie GU; Friedman H
    Adv Exp Med Biol; 1973; 29(0):499-505. PubMed ID: 4368788
    [No Abstract]   [Full Text] [Related]  

  • 20. The response of mice to type III pneumococcal polysaccharide: failure to detect thymus-derived suppressor cells.
    Warr GW; Ghaffar A; James K
    Cell Immunol; 1975 Jun; 17(2):366-73. PubMed ID: 236095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.